CAMBRIDGE POLYMER GROUP INC
Injectable biosealant and delivery device to seal needle tracks during lung biopsy procedures
- Sector
- Medtech
- Headquarters
- Woburn, MA
- Total capital
- $5.5M
- Federal grants
- $5.5M
- 10 awards · 2017–2023
- Rank in peer group#394 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 8 pending · first 2016
- Rank in peer group#125 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Preventing Pneuomothorax During Transthoracic Lung Biopsy$1.5M
- Federal grantHealth and Human S · Phase II · Preventing Pneuomothorax During Transthoracic Lung Biopsy$1.8M
- Federal grantHealth and Human S · Phase II · Preventing Pneuomothorax During Transthoracic Lung Biopsy$261K
- Federal grantHealth and Human S · Phase II · Degradable hydrogel for retinal tamponade (phase 2)$296K
- Federal grantHealth and Human S · Phase II · Degradable hydrogel for retinal tamponade (phase 2)$592K
- Federal grantHealth and Human S · Phase II · Degradable hydrogel for retinal tamponade (phase 2)$296K
- Federal grantHealth and Human S · Phase I · Preventing Pneumothorax During Transthoracic Lung Biopsy$147K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase I · Preventing Pneumothorax During Transthoracic Lung Biopsy$147K
- Federal grantHealth and Human S · Phase I · Degradable hydrogel for retinal tamponade$224K
- Federal grantHealth and Human S · Phase I · Degradable hydrogel for retinal tamponade$224K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#125 · top 23%
- Linked publications#72 · top 13%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 12- GrantedMethods For Making Oxidation Resistant Polymeric MaterialUSPTOUS 10,821,632
- GrantedThiolated Peg-pva HydrogelsUSPTOUS 9,873,769
- GrantedMethods For Making Oxidation-resistant Cross-linked Polymeric MaterialsUSPTOUS 9,433,705
Show all 12 patent records
- Methods For Making Oxidation Resistant Polymeric MaterialNov 3, 2020 · US 10,821,632Granted
- Thiolated Peg-pva HydrogelsJan 23, 2018 · US 9,873,769Granted
- Methods For Making Oxidation-resistant Cross-linked Polymeric MaterialsSep 6, 2016 · US 9,433,705Granted
- Methods For Making Oxidation Resistant Polymeric MaterialJun 21, 2016 · US 9,370,878Granted
- Tough HydrogelsApplication PCTUS2005034662Pending
- Methods For Making Oxidation Resistant Polymeric MaterialApplication PCTUS2005016283Pending
- Systems And Methods For Controlling And Forming Polymer GelsApplication PCTUS2005004773Pending
- Methods For Making Oxidation Resistant Polymeric MaterialApplication PCTUS2004000857Pending
- System And Methods For Reducing Interfacial Porosity In CementsApplication PCTUS2002008466Pending
- Thiolated Peg-pva HydrogelsApplication PCTUS2015039492Pending
- Hydrolyzed HydogelsApplication PCTUS2009066958Pending
- Methods For Making Oxidation-resistant Cross-linked Polymeric MaterialsApplication PCTUS2008051982Pending
Recent research by its founders
- Clinical Evaluation of an Inertial Measurement Unit in Monitoring Pelvic Position During Total Hip Arthroplasty20180 cites
- Corneal Cross-Linking With Verteporfin and Nonthermal Laser Therapy201710 cites
- Application of polymer-mesh device to remodel left ventricular–mitral valve apparatus in ischemic mitral regurgitation20174 cites
Related companies, and why
- ACTIOX LLCSimilar federal contract value in Medtech · null in contracts
- ALTITUDE PHARMA, INC.Similar federal contract value in Medtech · null in contracts
- Molecular Instruments, Inc.Similar federal contract value in Medtech · null in contracts
- PEROSPHERE TECHNOLOGIES INC.Similar federal contract value in Medtech · null in contracts
- WASATCH PHOTONICS, INC.Similar federal contract value in Medtech · null in contracts
- BMSEED, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .